TEVA vs. INCR

In the year-to-date period, TEVA achieves a -23.87% return, which is significantly lower than INCR's -1.43% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and INC Research Holdings Inc (INCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TEVA Sharpe Ratio is -0.01, which is higher than the INCR Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of TEVA and INCR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither TEVA nor INCR has paid dividends to shareholders.

The maximum TEVA drawdown since its inception was -90.80%, roughly equal to the maximum INCR drawdown of -94.32%. Use the drawdown chart below to compare losses from any high point for TEVA and INCR.

Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 16.55% compared to INC Research Holdings Inc (INCR) at 8.98%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than INCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and INC Research Holdings Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.